These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
488 related articles for article (PubMed ID: 7964958)
1. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry. Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958 [TBL] [Abstract][Full Text] [Related]
2. Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. Williams CD; Goldstone AH; Pearce RM; Philip T; Hartmann O; Colombat P; Santini G; Foulard L; Gorin NC J Clin Oncol; 1996 Sep; 14(9):2454-64. PubMed ID: 8823323 [TBL] [Abstract][Full Text] [Related]
3. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Majolino I; Pearce R; Taghipour G; Goldstone AH J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for survival of non-Hodgkin's lymphoma patients treated with high-dose chemotherapy and autologous bone marrow transplantation. de Kreuk M; Ossenkoppele GJ; Meijer CJ; Huijgens PC Bone Marrow Transplant; 1996 Jun; 17(6):963-71. PubMed ID: 8807101 [TBL] [Abstract][Full Text] [Related]
5. High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma: the EBMT experience. Lymphoma Working Party of the European Group for Bone Marrow Transplantation. Sweetenham JW; Proctor SJ; Blaise D; De Laurenzi A; Pearce R; Taghipour G; Goldstone AH; Laurenzi A [corrected to De Laurenzi A] Ann Oncol; 1994; 5 Suppl 2():155-9. PubMed ID: 7515646 [TBL] [Abstract][Full Text] [Related]
6. VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group. Santini G; Salvagno L; Leoni P; Chisesi T; De Souza C; Sertoli MR; Rubagotti A; Congiu AM; Centurioni R; Olivieri A; Tedeschi L; Vespignani M; Nati S; Soracco M; Porcellini A; Contu A; Guarnaccia C; Pescosta N; Majolino I; Spriano M; Vimercati R; Rossi E; Zambaldi G; Mangoni L; Rizzoli V J Clin Oncol; 1998 Aug; 16(8):2796-802. PubMed ID: 9704732 [TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. Stiff PJ; Dahlberg S; Forman SJ; McCall AR; Horning SJ; Nademanee AP; Blume KG; LeBlanc M; Fisher RI J Clin Oncol; 1998 Jan; 16(1):48-55. PubMed ID: 9440722 [TBL] [Abstract][Full Text] [Related]
8. Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma who failed to respond to first-line CHOP. Verdonck LF; Dekker AW; de Gast GC; van Kempen ML; Lokhorst HM; Nieuwenhuis HK J Clin Oncol; 1992 Dec; 10(12):1949-54. PubMed ID: 1453209 [TBL] [Abstract][Full Text] [Related]
9. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Caballero MD; Rubio V; Rifon J; Heras I; García-Sanz R; Vázquez L; Vidriales B; del Cañizo MC; Corral M; Gonzalez M; León A; Jean-Paul E; Rocha E; Moraleda JM; San Miguel JF Bone Marrow Transplant; 1997 Sep; 20(6):451-8. PubMed ID: 9313877 [TBL] [Abstract][Full Text] [Related]
10. Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group Registry data. Chopra R; Goldstone AH; Pearce R; Philip T; Petersen F; Appelbaum F; De Vol E; Ernst P J Clin Oncol; 1992 Nov; 10(11):1690-5. PubMed ID: 1403052 [TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma. Vose JM; Anderson JR; Kessinger A; Bierman PJ; Coccia P; Reed EC; Gordon B; Armitage JO J Clin Oncol; 1993 Oct; 11(10):1846-51. PubMed ID: 8105034 [TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma: the European Bone Marrow Transplant Group experience. EBMT Working Party for Lymphoma. Schouten HC; Colombat P; Verdonck LF; Gorin NC; Björkstrand B; Taghipour G; Goldstone AH Ann Oncol; 1994; 5 Suppl 2():147-9. PubMed ID: 8204514 [TBL] [Abstract][Full Text] [Related]
13. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200 [TBL] [Abstract][Full Text] [Related]
14. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission. Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717 [TBL] [Abstract][Full Text] [Related]
15. Role of a second transplant in the management of poor-prognosis lymphomas: a report from the European Blood and Bone Marrow Registry. Vandenberghe E; Pearce R; Taghipour G; Fouillard L; Goldstone AH J Clin Oncol; 1997 Apr; 15(4):1595-600. PubMed ID: 9193358 [TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study. Martelli M; Vignetti M; Zinzani PL; Gherlinzoni F; Meloni G; Fiacchini M; De Sanctis V; Papa G; Martelli MF; Calabresi F; Tura S; Mandelli F J Clin Oncol; 1996 Feb; 14(2):534-42. PubMed ID: 8636768 [TBL] [Abstract][Full Text] [Related]
17. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. Friedberg JW; Neuberg D; Stone RM; Alyea E; Jallow H; LaCasce A; Mauch PM; Gribben JG; Ritz J; Nadler LM; Soiffer RJ; Freedman AS J Clin Oncol; 1999 Oct; 17(10):3128-35. PubMed ID: 10506609 [TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study. Freedman AS; Takvorian T; Neuberg D; Mauch P; Rabinowe SN; Anderson KC; Soiffer RJ; Spector N; Grossbard M; Robertson MJ J Clin Oncol; 1993 May; 11(5):931-6. PubMed ID: 8487057 [TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation as consolidation therapy in newly diagnosed non-Hodgkin's lymphoma: long-term outcome. Montuoro A; Lalle M; Ingletto D Int J Oncol; 2000 Oct; 17(4):771-5. PubMed ID: 10995890 [TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study. Saez R; Dahlberg S; Appelbaum FR; Hartsock RJ; Lemaistre F; Coltman CA; Fisher RI Hematol Oncol; 1994; 12(2):75-85. PubMed ID: 8070756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]